|
Featured Articles
|
|
New Processes With Parallel Bioreactors
By Claudia M. Huether and Dr. Falk Schneider, DASGIP AG, Jülich
The pharmaceutical industry and regulatory authorities are facing new challenges in the development of new drugs that have complex interdependencies. The following provides some insights into the more notable advantages of using process-integrated data management in tandem with parallel bioreacreactor systems.
|
|
|
Three Words That Can Determine Patent Ownership
By Cathy Yarbrough, contributing editor
Three words that could determine ownership of an invention, “and hereby assigns,” are often missing from employment agreements in the life sciences industry.
|
|
|
|
|
|
Bulletin Board
|
|
Bio-G Webinar: Managing High Titers In Biopharmaceutical Manufacturing
July 31, 2012 | 1:00 PM PDT, 4:00 PM EDT
This webinar will outline a number of approaches to understanding and managing increased titers in commercial biopharmaceutical production, and explore the impact of titer on downstream chromatography steps, buffer preparation and hold steps, and practical techniques that can be used to alleviate bottlenecks.
|
|
|
|
|
|
|
Featured Multimedia
|
 |
|
Growth And Challenges Of Single-Use Technology |
|
Mani Krishnan, director of processing systems with EMD Millipore, discusses the challenges of single-use technologies, including scale limitations and cost of single-use, and how technology is adapting to those challenges. EMD Millipore highlighted the Mobius CellReady single-use bioreactor at the exhibition. |
|
|
|
